Virtual-reality for Upper Limb Rehabilitation in People With Parkinson's Disease
Clinical and Brain Functional MRI Effects of a Rehabilitative Training of Upper Limb Using Immersive Virtual Reality in People With Parkinson's Disease
1 other identifier
interventional
70
1 country
1
Brief Summary
The aim of this study is to assess the effect of 8-week physiotherapy training using immersive virtual reality (VR-training) compared to a physiotherapy training performed in a real setting (RS-training) on handwriting and touch screen technology-based activities, brain functional activity and cognition in patients with Parkinson's disease (PD). Both groups will perform upper limb exercises focused at improving movement amplitude and speed during several activities such as writing and using touch screen-technology. Participants randomized to VR-training (N=20) will perform exercises under the augmented visual feedback induced by the VR aimed at stimulating movement amplitude and speed. Participants randomized to RS-training (N=20) will perform exercises in a real setting. Before training, after training (8 weeks) and at 3-month follow-up (20 weeks), subjects with PD will undergo clinical evaluations (neurological, physiotherapy and neuropsychological) while taking their regular anti-parkinsonian drugs (on-medication state). MRI scans will be acquired at each time-point to assess brain activity reorganization during off state (MRI scans will be acquired at least 12 hours after the regular evening dopaminergic therapy administration to mitigate the pharmacological effects on neural activity). A sample of matched healthy subjects (N=30) will undergo clinical, physiotherapy, neuropsychological and MRI assessments only at study entry as a benchmark.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started May 2021
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedStudy Start
First participant enrolled
May 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2024
CompletedApril 8, 2025
April 1, 2025
3.3 years
May 3, 2021
April 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Letters amplitude
Changes in letters amplitude during a repetitive handwriting task on a writing tablet. Higher amplitude reflects a better performance. Assessment during ON medication phase
Baseline, after 8 weeks of training and after 3-month follow-up
Secondary Outcomes (15)
Systematic Screening of Handwriting Difficulties test (SOS)
Baseline, after 8 weeks of training and after 3-month follow-up
Systematic Screening of Handwriting Difficulties test (SOS) on a tablet
Baseline, after 8 weeks of training and after 3-month follow-up
Repetitive Prewriting task on tablet
Baseline, after 8 weeks of training and after 3-month follow-up
Funnel task on tablet
Baseline, after 8 weeks of training and after 3-month follow-up
Brain functional changes during hand-tapping in a virtual reality setting
Baseline, after 8 weeks of training and after 3-month follow-up
- +10 more secondary outcomes
Study Arms (3)
VR-training
EXPERIMENTALUpper limb/handwriting exercises in an immersive virtual reality setting
RS-training
ACTIVE COMPARATORThe same upper limb/handwriting exercises in a real setting
Healthy subjects
OTHERAge- and sex-matched healthy subjects recruited to compare clinical and fMRI characteristics at baseline.
Interventions
Progressively difficult multimodal physiotherapy under the augmented visual feedback induced by the VR. Participants will wear a head-mounted display and their upper limb movements during the training will be captured by a motion tracker. Patients will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) under the augmented visual feedback provided by the use of VR in increasingly wide range of movement; active upper limb multi-joints movements under the augmented visual feedback provided by the use of VR (following trajectories designed in the virtual space - movement involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage in VR context on a tablet and a smartphone. 30 minutes of exercises, 2 times a week, for 8 weeks.
Participants will perform progressively difficult multimodal physiotherapy in a real setting. Participants will be encouraged to perform their upper limb movements during the training in order to perform faster and ampler movements. They will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) in increasingly wide range of movement under the feedback provided by therapist; active upper limb multi-joints movements under the feedback provided by the therapist (following trajectories designed on a table or on a blackboard - movements involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage under the supervision of the therapist. 30 minutes of exercises, 2 times a week, for 8 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic Parkinson's disease
- H\&Y scale ≤ 3 while on medication
- Age ≤ 85 years
- Right-handedness with the Edinburgh Handedness Inventory Quotient
- Right-side involvement according to H\&Y and Movement Disorder Society Unified Parkinson's Disease Rating Scale III (MDS-UPDRS III)
- Handwriting difficulty defined by a score greater than or equal to 1 on item II.7 of the MDS-UPDRS
- Oral and written informed consent to study participation
- Sex-matched and age-matched with PD patients;
- Right-handed;
- Oral and written informed consent to study participation.
You may not qualify if:
- Mini-Mental State Examination lower than 24;
- Visual impairments that interfere with the immersive virtual environment;
- (Other) upper limb deficits impeding handwriting;
- History of (other) systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
- Family history of neurodegenerative disorders;
- History of alcohol and/or psychotropic drug abuse;
- Contraindications for MRI;
- Denied oral and written informed consent to study participation.
- Mini-Mental State Examination lower than 28;
- Visual impairments that interfere with the immersive virtual environment;
- History of systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
- History of alcohol and/or psychotropic drug abuse;
- Contraindications for MRI;
- Denied oral and written informed consent to study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS San Raffaele
Milan, 20132, Italy
Related Publications (1)
Corbetta D, Sarasso E, Gardoni A, Zenere L, Balestrino R, Smits-Engelsman B, Pelosin E, Filippi M, Agosta F. Construct validity, intrarater and interrater reliability of the Italian version of the systematic screening of handwriting difficulties (SOS) test in people with Parkinson's disease. J Neurol. 2025 Sep 8;272(9):620. doi: 10.1007/s00415-025-13365-w.
PMID: 40920242DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Physiotherapist, neurologists, neuropsychologists and radiologist assessing the patients are blinded to group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 6, 2021
Study Start
May 17, 2021
Primary Completion
September 6, 2024
Study Completion
September 6, 2024
Last Updated
April 8, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share